Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Federal Reserve Governor Milan once again calls for a significant rate cut in December
International Business Settlement: Acquired approximately 247 bitcoins between October 17 and November 7
Monad announces tokenomics: total supply of 100 billions tokens, 3% to be distributed via airdrop
Trending news
MoreOverview of Monad Tokenomics: 49.4% of the total supply will be unlocked on the first day of mainnet launch, with 10.8% entering circulation through public sale and airdrop, and 38.5% managed by the Monad Foundation.
Federal Reserve Governor Milan once again calls for a significant rate cut in December
Crypto prices
More
